scholarly journals Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan

2016 ◽  
Vol 7 (5) ◽  
pp. 737-743 ◽  
Author(s):  
Karen Kurtyka ◽  
Rie Nishikino ◽  
Chie Ito ◽  
Kim Brodovicz ◽  
Yong Chen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Health Insurance ◽  
Dipeptidyl Peptidase ◽  
Inhibitor Therapy ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Diabetes Patients

scholarly journals Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

2016 ◽  
Vol Volume 8 ◽  
pp. 521-529 ◽  
Author(s):  
Unchalee Permsuwan ◽  
Piyameth Dilokthornsakul ◽  
Surasak Saokaew ◽  
Kednapa Thavorn ◽  
Nathorn Chaiyakunapruk
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Diabetes Patients

scholarly journals Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis

Diabetes Care ◽  
2018 ◽  
Vol 41 (4) ◽  
pp. e52-e55 ◽  
Author(s):  
Tomohide Yamada ◽  
Nobuhiro Shojima ◽  
Hisashi Noma ◽  
Toshimasa Yamauchi ◽  
Takashi Kadowaki
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Dipeptidyl Peptidase ◽  
Inhibitor Therapy ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document